Drug Trial Radar · NCT00239681
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
Last checked: Nov 20, 2026Latest source record: Mar 24, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
17,802
Actual
Start
Feb 2003
Primary completion
Sep 2008
Study completion Sep 2008
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Oct 17, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and effectiveness of long-term therapy with rosuvastatin compared with a placebo, and to evaluate whether treatment with rosuvastatin might be effective in reducing the risk of major cardiovascular events.
Conditions
- Elevated High-sensitivity C-Reactive Protein (hsCRP)
Interventions
RosuvastatinDrug
Oral
PlaceboOther
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Major Cardiac Event (Cardiovascular Death, Stroke, Myocardial Infarction, Hospitalization Due to Unstable Angina or Arterial Revascularization)Time frame: up to 5 years
Locations
856 sites in 27 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Calera, Alabama
Research Site
Columbiana, Alabama
Research Site
Decatur, Alabama
Research Site
Graysville, Alabama
Research Site
Haleyville, Alabama
Research Site
Hartselle, Alabama
Research Site
Huntsville, Alabama
Research Site
Mobile, Alabama
Research Site
Montgomery, Alabama
Research Site
Muscle Shoals, Alabama
Research Site
South Birmingham, Alabama
Research Site
Tuscumbia, Alabama
Research Site
Mesa, Arizona
Research Site
Phoenix, Arizona
Research Site
Scottsdale, Arizona
Research Site
Tucson, Arizona
Research Site
Fayetteville, Arkansas
Research Site
Hot Springs, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Pine Bluff, Arkansas
Research Site
Alhambra, California
Research Site
Azusa, California
Research Site
Berkeley, California
Research Site
Beverly Hills, California
Research Site
Burlingame, California
Research Site
Carmichael, California
Research Site
Concord, California
Research Site
Culver City, California
Research Site
Daly City, California
Research Site
Folsom, California
Research Site
Foothill Ranch, California
Research Site
Fountain Valley, California
Research Site
Fresno, California
Research Site
Garden Grove, California
Research Site
Inglewood, California
Research Site
Irvine, California
Research Site
La Jolla, California
Research Site
La Mesa, California
Research Site
Languna Niguel, California
Showing 40 of 856 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.